|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Synthes Inc. (SYST.VX), a major Swiss-based spinal implant maker. |
|---|---|
| Transferring Party | N Spine, a private developer of implantables to treat lumbar spinal disorders. |
| Sector | Medical Devices |
| Date | November 13, 2007 |
| Analysis N Spine's product dynamic stabilization rods allows minimal access techniques, helps avoid interference with the facet joints, and enables close placement of pedicle screws, which is important when used to treat lumbar disorders in smaller patients. The product line is compatible with Synthes’ Pangea and Click’X pedicle screws and enhances the range of choices available to surgeons, via Synthes global direct sales force. Deal value -- $30m plus $45m based on milestones. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |